Cargando…

Correction to: Methylation of ZNF331 is an independent prognostic marker of colorectal cancer and promotes colorectal cancer growth

Detalles Bibliográficos
Autores principales:	Wang, Yuzhu, He, Tao, Herman, James G., Linghu, Enqiang, Yang, Yunsheng, Fuks, François, Zhou, Fuyou, Song, Linjie, Guo, Mingzhou
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5851308/ https://www.ncbi.nlm.nih.gov/pubmed/29569636 http://dx.doi.org/10.1186/s13148-018-0467-2

Ejemplares similares

Methylation of ZNF331 is an independent prognostic marker of colorectal cancer and promotes colorectal cancer growth
por: Wang, Yuzhu, et al.
Publicado: (2017)

Re-assessing ZNF331 as a DNA methylation biomarker for colorectal cancer
por: Vedeld, Hege Marie, et al.
Publicado: (2018)

RASSF10 suppresses colorectal cancer growth by activating P53 signaling and sensitizes colorectal cancer cell to docetaxel
por: Guo, Jing, et al.
Publicado: (2015)

The novel colorectal cancer biomarkers CDO1, ZSCAN18 and ZNF331 are frequently methylated across gastrointestinal cancers
por: Marie Vedeld, Hege, et al.
Publicado: (2015)

Methylation of DIRAS1 promotes colorectal cancer progression and may serve as a marker for poor prognosis
por: Zheng, Ruipan, et al.
Publicado: (2017)

Association of ZNF331 and WIF1 methylation in peripheral blood leukocytes with the risk and prognosis of gastric cancer
por: Nie, Chuang, et al.
Publicado: (2021)

Retinoic acid-induced 2 (RAI2) is a novel tumor suppressor, and promoter region methylation of RAI2 is a poor prognostic marker in colorectal cancer
por: Yan, Wenji, et al.
Publicado: (2018)

Silencing NKD2 by promoter region hypermethylation promotes gastric cancer invasion and metastasis by up-regulating SOX18 in human gastric cancer
por: Jia, Yan, et al.
Publicado: (2015)

Epigenetic silencing of TMEM176A activates ERK signaling in human hepatocellular carcinoma
por: Li, Hongxia, et al.
Publicado: (2018)

Methylation of CHFR sensitizes esophageal squamous cell cancer to docetaxel and paclitaxel
por: Yun, Tianyang, et al.
Publicado: (2015)

Epigenetic silencing of TMEM176A promotes esophageal squamous cell cancer development
por: Wang, Ying, et al.
Publicado: (2017)

Methylation of DACT2 accelerates esophageal cancer development by activating Wnt signaling
por: Zhang, Meiying, et al.
Publicado: (2016)

Silencing HOXD10 by promoter region hypermethylation activates ERK signaling in hepatocellular carcinoma
por: Guo, Yulin, et al.
Publicado: (2017)

ZNF3 regulates proliferation, migration and invasion through MMP1 and TWIST in colorectal cancer: ZNF3 regulates proliferation, migration and invasion in colorectal cancer
por: Du, Le, et al.
Publicado: (2022)

Serum oxidative stress is an independent prognostic marker in colorectal cancer
por: Sugimoto, Kiichi, et al.
Publicado: (2019)

Expression of ZNF281 in colorectal cancer correlates with response to radiotherapy and survival
por: Qin, Changjiang, et al.
Publicado: (2023)

Identification of ZNF26 as a Prognostic Biomarker in Colorectal Cancer by an Integrated Bioinformatic Analysis
por: Liu, Jiaxin, et al.
Publicado: (2021)

DNA methylation markers for breast cancer prognosis: Unmasking the immune component
por: Dedeurwaerder, Sarah, et al.
Publicado: (2012)

Telomerase is an independent prognostic marker of overall survival in patients with colorectal cancer
por: Bertorelle, R, et al.
Publicado: (2013)

Cancer-specific tissue-resident memory T-cells express ZNF683 in colorectal cancer
por: Kitakaze, Masatoshi, et al.
Publicado: (2023)

Epigenetic Mechanisms Are Involved in the Oncogenic Properties of ZNF518B in Colorectal Cancer
por: Gimeno-Valiente, Francisco, et al.
Publicado: (2021)

Targeted DNA demethylation of the ZNF334 promoter inhibits colorectal cancer growth
por: Yang, Bin, et al.
Publicado: (2023)

Prognostic markers for colorectal cancer
por: Tyrrell, Helen E.J., et al.
Publicado: (2018)

Epigenetic changes in colorectal cancer
por: Jia, Yan, et al.
Publicado: (2013)

Identification of ZNF704 as a Novel Oncogene and an Independent Prognostic Marker in Chondrosarcoma
por: Chen, Changbao, et al.
Publicado: (2021)

CD133 expression is an independent prognostic marker for low survival in colorectal cancer
por: Horst, D, et al.
Publicado: (2008)

Expression of circZNF609 is Down-Regulated in Colorectal Cancer Tissue and Promotes Apoptosis in Colorectal Cancer Cells by Upregulating p53
por: Zhang, Xiaoyun, et al.
Publicado: (2019)

MiR-203 Suppresses ZNF217 Upregulation in Colorectal Cancer and Its Oncogenicity
por: Li, Zewu, et al.
Publicado: (2015)

Prognostic DNA methylation markers for sporadic colorectal cancer: a systematic review
por: Draht, Muriel X. G., et al.
Publicado: (2018)

DNA-methylated gene markers for colorectal cancer in TCGA database
por: Zhang, Hui, et al.
Publicado: (2020)

Downregulation of ZNF365 by methylation predicts poor prognosis in patients with colorectal cancer by decreasing phospho-p53 (Ser15) expression
por: Wang, Chan, et al.
Publicado: (2020)

MALDI-imaging reveals thymosin beta-4 as an independent prognostic marker for colorectal cancer
por: Gemoll, Timo, et al.
Publicado: (2015)

Serum PlGF and EGF are independent prognostic markers in non-metastatic colorectal cancer
por: Schölch, Sebastian, et al.
Publicado: (2019)

High expression of NOLC1 as an independent prognostic factor for survival in patients with colorectal cancer
por: Sun, Zhiwei, et al.
Publicado: (2023)

Retraction: MiR-203 Suppresses ZNF217 Upregulation in Colorectal Cancer and Its Oncogenicity
Publicado: (2020)

Cancer stem cell marker expression and methylation status in patients with colorectal cancer
por: Mersakova, Sandra, et al.
Publicado: (2022)

SMOC2, an intestinal stem cell marker, is an independent prognostic marker associated with better survival in colorectal cancers
por: Jang, Bo Gun, et al.
Publicado: (2020)

Clinical Implications of Systemic Inflammatory Response Markers as Independent Prognostic Factors in Colorectal Cancer Patients
por: Paik, Kwang Yeol, et al.
Publicado: (2014)

Cdc7 overexpression is an independent prognostic marker and a potential therapeutic target in colorectal cancer
por: Melling, Nathaniel, et al.
Publicado: (2015)

Long-term follow-up of nonspecific small bowel ulcers with a benign course and no requirement for surgery: is this a distinct group?
por: Wang, Weifeng, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_atpu60k628n7e06isokvgh0ts1